NASDAQ:COAG | Free Cash Flow | Hemab Therapeutics Holdings, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$21.58M$112,000.00-$21.7M
2025-03-31-$13.03M$16,000.00-$13.05M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income